Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 19.05
-0.86 (-4.32%)
At close: Mar 19, 2026
Frontier Biotechnologies Revenue
In the year 2025, Frontier Biotechnologies had annual revenue of 143.67M CNY with 10.96% growth. Frontier Biotechnologies had revenue of 40.29M in the quarter ending December 31, 2025, with 6.52% growth.
Revenue
143.67M
Revenue Growth
+10.96%
P/S Ratio
49.67
Revenue / Employee
475.72K
Employees
524
Market Cap
7.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 143.67M | 14.20M | 10.96% |
| Dec 31, 2024 | 129.47M | 15.22M | 13.32% |
| Dec 31, 2023 | 114.25M | 29.51M | 34.82% |
| Dec 31, 2022 | 84.74M | 44.24M | 109.22% |
| Dec 31, 2021 | 40.50M | -6.12M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition